Clinical trials
Phase 3 Tuberculosis trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| All India Institute of Medical Sciences | 4 |
| Tuberculosis Research Centre, India | 4 |
| Ministry of Science and Technology, India | 2 |
| Médecins Sans Frontières, France | 2 |
| Centers for Disease Control and Prevention | 1 |
| Indian Council of Medical Research | 1 |
| Johns Hopkins University | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 16 |
| Tuberculosis, Pulmonary | 5 |
| Tuberculosis, Multidrug-Resistant | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Bacterial Infections | 2 |
| HIV Infections | 2 |
| Mycobacterium Infections | 2 |
| Extensively Drug-Resistant Tuberculosis | 1 |
| Gram-Positive Bacterial Infections | 1 |
| Infections | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.